aromatase inhibitor

(redirected from Aromatase inhibitors)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Aromatase inhibitors: tamoxifen

aromatase inhibitor

n. Abbr. AI
Any of several drugs that affect the levels of steroids in the blood by inhibiting the enzyme aromatase. Aromatase inhibitors are used especially to lower estrogen levels to control the growth or prevent the recurrence of estrogen-sensitive tumors in post-menopausal women with breast cancer.

aromatase inhibitor

n
any of a class of drugs that inhibit the action of aromatase: used in the treatment of breast and ovarian cancer
Mentioned in ?
References in periodicals archive ?
The researchers found that tamoxifen, raloxifene, and the aromatase inhibitors exemestane and anastrozole correlated with a reduced incidence of invasive breast cancer in placebo-controlled trials (risk ratios, 0.69, 0.44, and 0.45, respectively).
"Aromatase inhibitors are effective at killing cancer cells, but within a decade post-surgery around 30 per cent of patients will relapse and see their cancer return, usually because the cancer cells have adapted to the drug.
Keywords: Anastrozole, Aromatase inhibitors, Breast cancer, Serum estrogen level.
Aromatase inhibitors, such as exemestane, anastrazole, and letrazole, are drugs which block this conversion in peripheral tissues.
After surgery, chemotherapy, and radiation, she has been on Tamoxifen and then aromatase inhibitors for five years.
However, several azoles have adverse health effects such as carcinogenesis via CYP (e.g., CYP1A, 2B, 3A)-mediated metabolism in mammals and other non-targeted organisms, and these chemicals are also known as aromatase inhibitors (AIs) which block cytochrome P450 aromatase (P450arom) activity, resulting in a decrease in estrogen production (Allen et al., 2006; Zarn et al., 2003; Taxvig, 2008).
Aromatase inhibitors work by blocking the production of the hormone oestrogen, stopping its ability to fuel some breast cancers.
Faslodex is intended for use in women who have oestrogen-receptor-positive, locally advanced breast cancer or breast cancer that has spread to other parts of the body, who have not already had treatment with hormonal therapy (aromatase inhibitors or tamoxifen).
In women diagnosed with breast cancer, taking tamoxifen and/or aromatase inhibitors reduces the risk of developing cancer in their other breast, according to a study published online Oct.
In two large studies published in The Lancet, a class of hormone therapy drugs called aromatase inhibitors and bone-preserving drugs called bisphosphonates improved survival and recurrence rates in postmenopausal women with early breast cancer.
The findings are expected to influence clinical guidelines on prescribing aromatase inhibitors, which were already known to be effective at preventing cancer recurrence.
Estrogens are thought to help close epiphyseal growth plates; the idea of giving aromatase inhibitors (AIs) is to block aromatase from converting androgens to estrogens in boys so that their growth plates stay open a bit longer and they grow taller.